Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

CeNes Pharmaceuticals

CeNes, the Cambridge-based pharmaceuticals manufacturer with 15 staff, is to be acquired by Paion of Germany for £11m.

CeNes is to raise £11m in a share placing to fund the development of a pain relief drug.

CeNes Pharmaceuticals has acquired TheraSci, the developer of drugs for the central nervous system, for up to £3.7m.

CeNes Pharmaceuticals has sold its ion channel technology development business to Xention Discovery, a new Cambridge-based company backed by venture capitalist MVM, for £0.8m.

CeNes Pharmaceuticals has sold its cognitive testing division to a management team operating under the name of Cambridge Cognition for up to £1m.

CeNes Pharmaceuticals has acquired Management Dynamics Cambridge, a specialist organisational psychology company, and merged it with its own cognition division to create a new business called Cambridge Cognition.